VPS39 Antikörper (AA 263-490)
Kurzübersicht für VPS39 Antikörper (AA 263-490) (ABIN7175353)
Target
Alle VPS39 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 263-490
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Vam6/Vps39-like protein (263-490AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- VPS39 (Vacuolar Protein Sorting 39 Homolog (VPS39))
-
Andere Bezeichnung
- VPS39
-
Hintergrund
-
Background: Regulator of TGF-beta/activin signaling, inhibiting SMAD3- and activating SMAD2-dependent transcription. Acts by interfering with SMAD3/SMAD4 complex formation, this would lead to inhibition of SMAD3-dependent transcription and relieve SMAD3 inhibition of SMAD2-dependent promoters, thus increasing SMAD2-dependent transcription. Does not affect TGF-beta-induced SMAD2 or SMAD3 phosphorylation, nor SMAD2/SMAD4 complex formation.
Aliases: A230065P22Rik antibody, AW743070 antibody, FLJ21681 antibody, FLJ46546 antibody, hVam6p antibody, KIAA0770 antibody, RP23-348L16.12 antibody, TLP antibody, TRAP1 like protein antibody, Vacuolar protein sorting 39 antibody, Vacuolar protein sorting 39 homolog antibody, VAM6 antibody, Vam6/Vps39 like antibody, Vam6/Vps39 like protein antibody, Vam6/Vps39-like protein antibody, VPS 39 antibody, Vps39 antibody, VPS39_HUMAN antibody
-
UniProt
- Q96JC1
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-